Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000458514 | SCV000550077 | uncertain significance | Gastrointestinal stromal tumor | 2025-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 956 of the KIT protein (p.Arg956Trp). This variant is present in population databases (rs587778433, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with KIT-related conditions. ClinVar contains an entry for this variant (Variation ID: 134627). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV001016829 | SCV001177827 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-05-15 | criteria provided, single submitter | clinical testing | The p.R956W variant (also known as c.2866C>T), located in coding exon 21 of the KIT gene, results from a C to T substitution at nucleotide position 2866. The arginine at codon 956 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002483219 | SCV002787372 | uncertain significance | Gastrointestinal stromal tumor; Piebaldism; Acute myeloid leukemia; Cutaneous mastocytosis; Germ cell tumor of testis | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000458514 | SCV004190371 | uncertain significance | Gastrointestinal stromal tumor | 2023-07-11 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121320 | SCV000085491 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |